Institution statistics

AMGEN LIMITED -  

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 25.395.897 0 1
2018 0 6.248.931 0 2
2016 0 6.000.000 0 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
ELI LILLY AND COMPANY LIMITED3
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN3
NOVARTIS PHARMA3
PFIZER LIMITED3
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT3
TAKEDA DEVELOPMENT CENTRE EUROPE3
ASTELLAS PHARMA EUROPE BV2
ASTRAZENECA AB2
BAYER AKTIENGESELLSCHAFT2
EUROPEAN PATIENTS' FORUM2
F HOFFMANNLA ROCHE2
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT2
GRUNENTHAL2
INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS2
JANSSEN PHARMACEUTICA NV2
KATHOLIEKE UNIVERSITEIT LEUVEN2
MERCK SHARP & DOHME CORP2
UCB BIOPHARMA2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITATSKLINIKUM ERLANGEN2
UNIVERSITY OF NEWCASTLE UPON TYNE2
ABBVIE1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACTELION PHARMACEUTICALS1
AGENZIA ITALIANA DEL FARMACO1
ALEXION SERVICES EUROPE SPRL1
ALZHEIMER EUROPE1
ASTRAZENECA1
BAYER1
BAYER PHARMA1
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER1
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL1
COVANCE LABORATORIES1
CSL BEHRING1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
ERASMUS UNIVERSITEIT ROTTERDAM1
ERESEARCH TECHNOLOGY INC1
EUROPEAN AIDS TREATMENT GROUP EV1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE1
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION1
FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG1
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES1
FRIEDRICHALEXANDERUNIVERSITAET ERLANGEN NUERNBERG1
FUNDACIO SANT JOAN DE DEU1
FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA1
H LUNDBECK AS1
HEALTH TECHNOLOGY ASSESSMENT INTERNATIONAL SOCIETY1
ICON CLINICAL RESEARCH LIMITED1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER1
INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD1
INSTITUTO TUMORI ""GIOVANNI PAOLO II""1
ISTITUTO EUROPEO DI ONCOLOGIA1
IXSCIENT LIMITED1
LA SANTE EPIDEMIOLOGIE EVALUATION ET RECHERCHE LASER1
MCROBERTS BV1
MINDBYTES1
MUSCULAR DYSTROPHY GROUP OF GREAT BRITAIN AND NORTHERN IRELAND1
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE1
NORGES TEKNISKNATURVITENSKAPELIGE UNIVERSITET NTNU1
NOVO NORDISK1
PENUMOLOGISCHES FORSCHUNGSINSTITUTAN DER LUNGENCLINIC GROSSHANSDORF1
ROBERT BOSCH GESELLSCHAFT FUR MEDIZINISCHE FORSCHUNG MBH1
SANOFIAVENTIS1
STEINBEISSER PROJECT MANAGEMENT UG1
STICHTING VU1
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL1
TAKEDA PHARMACEUTICALS INTERNATIONAL1
TEVA PHARMACEUTICAL INDUSTRIES LIMITED1
THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE FOUNDATION FOR MEDICAL RESEARCH INFRASTRUCTURAL DEVELOPMENT AND HEALTH SERVICES NEXT TO THE MEDICAL CENTER TEL AVIV1
THE SYNERGIST1
THE UNIVERSITY OF SHEFFIELD1
UNIVERSITA DEGLI STUDI DI SASSARI1
UNIVERSITA VITASALUTE SAN RAFFAELE1
UNIVERSITAET ZUERICH1
UNIVERSITY COLLEGE DUBLIN1
UNIVERSITY OF BIRMINGHAM1
UNIVERSITY OF BOLOGNA1
UNIVERSITY OF NORTHUMBRIA AT NEWCASTLE1
UPPSALA UNIVERSITET1
VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV1
VITAL TRANSFORMATION1
ZORGINSTITUUT NEDERLAND1
Constancy:

Total number of partners:114

Partner loyalty:
Frequent Partner: (> 2 projects): 18
Rare Partner: 96

Frequent / Rare Partner Ratio: 0.19

Diversity:

Subjects:
Subject:No:
Diversity index:0
Categories:
Category:No:

Project overview:

Start dateProjectacronymrolefundingpartners
2019-04-01Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement MOBILISE-Dparticipant25.395.89734
2018-06-01The GetReal Initiative GetReal Initiativeparticipant1.750.00017
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93134
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum